Tari Leslie

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$9,700.00
Insider Sells Quantity
8
Insider Sells Sum
$120,862.40

Insider Activity of Tari Leslie

According to the SEC Form 4 filings, Tari Leslie, being in a position of

  1. CHIEF SCIENTIFIC OFFICER at Cidara Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 2682 shares for $49,520,
    over all time since 2022-01-05, has bought 10000 shares for $9,700, and sold 80967 shares for $120,862.

The largest purchase of all time was on 2023-08-14 and amounted to 10000 shares of Cidara Therapeutics, Inc. for $9,700.

The largest sale of all time was on 2025-03-11 and amounted to 1773 shares of Cidara Therapeutics, Inc. for $38,940.

Biography of Tari Leslie

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$49,5202100

Comparison of Insiders on Amount of Buys and Sells

2025-03-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
1,773
0.0169%
$21.96$38,940+7.05%
2024-09-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
909
0.0126%
$11.64$10,580+72.46%
2024-03-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
21,029
0.0235%
$0.67$14,085-0.98%
2023-09-11SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
18,469
0.0202%
$0.95$17,509-27.31%
2023-08-14PurchaseCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
10,000
0.0118%
$0.97$9,700-21.9%
2023-03-13SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
7,562
0.0085%
$1.53$11,570-45.66%
2023-01-12SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
11,814
0.015%
$1.20$14,177-13.33%
2022-09-12SaleCidara Therapeutics, Inc.
CDTX
CHIEF SCIENTIFIC OFFICER
18,159
0.026%
$0.68$12,437+51.03%
2022-01-05SaleCidara Therapeutics, Inc.
CDTX
Chief Scientific Officer
1,252
0.002%
$1.25$1,565-41.37%
Total: 9
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.